Diabetes webYvonne Dennis and Deborah Nummy are celebrating 60 years of managing Type 1 Diabetes. Over the last six decades, treatment for Type 1 Diabetes looks a lot different than it did back then, however, strides in disease management, insulin technology and public knowledge has helped dramatically change the way diabetes can be treated. It has saved the lives of patients like Yvonne and Deborah, thanks to the care provided by Amy Warriner, MD (Associate Professor, Endocrinology, Diabetes and Metabolism) and other physicians in the division of Endocrinology, Diabetes and Metabolism. Read the UAB News Article.

Noha SharafeldinNoha Sharafeldin, PhD (Instructor, Hematology and Oncology) was awarded the Amy Strelzer Manasevit Research Program for the Study of Post-Transplant Complications grant funded by the Be the Match Foundation. With this grant, Dr. Sharafeldin plans to study the impact of cognitive training for patients after allogeneic hematopoietic cell transplantation. Kudos, Dr. Sharafeldin!

AroraPankaj Arora, MD (Assistant Professor, Cardiovascular Disease) received the 2019 UAB School of Medicine Pittman Scholar Award. Dr. Arora’s lab focuses on the role of natriuretic peptide signaling in cardiometabolic disease. Congrats, Dr. Arora!


Drs. Axley and Shipley IM Residents Page Axley, MD (PGY3) and Lindsey Shipley, MD (PGY1) recently published a review of Non-Alcoholic Fatty Liver Disease. The publication was listed as one of the top 10 most read articles in Gastroenterology and Endoscopy News in 2018. It discusses the growth of NAFLD and its relation to obesity. Congrats, Drs. Axley and Shipley!

Speer Tolwani Stofan webL to R: UAB pharmacist Dr. Rajesh Speer, nephrologist Dr. Ashita Tolwani and UAB research nurse Brenda Stofan, RN.Ashita Tolwani, MD (Professor, Nephrology) has established the Tolwani Innovation Fund in Nephrology that will support investigators in their pursuit of product development and innovation for kidney-related diseases. This fund was inspired by Dr. Tolwani's experience developing an anticoagulant solution that can be safely administered to patients receiving continuous renal replacement therapy in the ICU. The solution is now patented, and the Division hopes to spur similar innovation with this fund.